Abraham Ceesay - Chief Executive Officer, Director at Rapport Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Executive Officer, Director
Issuer Symbol
RAPP on Nasdaq
All Insider Reports
All Insider Reports

Abraham Ceesay - trading volume in the past year for Rapport Therapeutics, Inc.

Holdings reported by Abraham Ceesay for Rapport Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 567,913 $17,625,747 $31.04 17 Dec 2025 Direct
Common Stock 81,729 $2,335,814 $28.58 17 Dec 2025 By Ceesay Family Irrevocable Trust
Common Stock 30,895 $958,968 $31.04 17 Dec 2025 By Dorothy Ceesay Irrevocable Trust
Stock Option (Right to Buy) 428,000 03 Feb 2025 Direct Common Stock

Transactions reported by Abraham Ceesay for Rapport Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.